Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
[Anesthesia for pneumothorax surgery in a patient with type II chronic respiratory failure associated with inclusion body myositis].
[inclusion body myositis]
A
40
-
year
-old
man
was
scheduled
for
video
assisted
thoracoscopic
surgery
due
to
pneumothorax
.
He
had
been
diagnosed
with
inclusion
body
myositis
and
received
nocturnal
non-invasive
positive
pressure
ventilation
.
Anesthesia
was
induced
with
propofol
,
remifentanil
,
and
rocuronium
,
and
maintained
with
propofol
,
remifentanil
and
fentanyl
.
The
dosage
of
rocuronium
was
10
mg
.
Although
we
administered
neostigmine
at
the
end
of
the
operation
and
TOF
ratio
was
over
90
%
,
he
was
transported
to
the
ICU
with
tracheal
intubation
because
of
poor
spontaneous
respiration
.
On
POD
1
,
the
tracheal
tube
was
extubated
and
NPPV
was
administered
again
.
Minitrach
was
inserted
on
POD
2
,
and
he
left
the
ICU
on
POD
4
.
Generally
,
in
patients
with
myopathy
the
dose
of
muscle
relaxant
should
be
decreased
in
proportion
to
their
muscle
atrophy
.
Rocuronium
10
mg
was
administered
in
this
case
and
we
thought
it
could
be
antagonized
by
neostigmine
,
but
extubation
on
the
day
of
operation
was
impossible
.
We
think
this
is
not
because
of
the
residual
effect
of
muscle
relaxant
,
but
because
of
decreases
in
pulmonary
function
.
In
this
case
,
we
expected
long
-term
mechanical
ventilation
might
be
necessary
,
but
he
showed
a
good
postoperative
course
owing
to
minimally
invasive
surgery
,
NPPV
,
and
suctioning
of
sputum
via
Minitrach
.
Diseases
Validation
Diseases presenting
"administered neostigmine at the end of the operation"
symptom
inclusion body myositis
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom